Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the αvβ3 and αvβ5 integrins

Journal of Cellular Physiology

Volumn 176, Issue 3, 1998, Pages 482-494

  Sung, V ^a   Stubbs III, J T ^b   Fisher, L ^b   Aaron, A D ^a   Thompson, E W ^a,c,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRONECTIN; GLYCOPROTEIN; INTEGRIN; RECOMBINANT PROTEIN; SIALOPROTEIN; SYNTHETIC PEPTIDE; VITRONECTIN RECEPTOR;

ARTICLE; BONE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031856539     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K     Document Type: Article

References (67)

1. Agrez, M., Chen, A., Cone, R.I., Pytela, R., and Sheppard, D. (1994) The αvβ6 integrin promotes proliferation of colon carcinoma cells through a unique region of the β6 cytoplasmic domain. J. Cell. Biol., 127:547-556.
2. Bautista, D.S., Xuan, J.-W., Hota, C., Chambers, A.F., and Harris, J.F. (1994) Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J. Biol. Chem., 37:23280-23285.
3. Bellahcene, A., Merville, M.-P., and Castronovo, V. (1995) Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res., 54:2823-2826.
4. Bellahcene, A., Kroll, M., Liebens, F., and Castronovo, V. (1996a) Bone sialoprotein expression in primary human breast cancer is associated with bone metastasis development. J. Bone Miner. Res., 11:665-670.
5. Bellahcene, A., Menard, S., Bufalino, R., Moreau, L., and Castronovo, V. (1996b) Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int. J. Cancer, 69:350-353.
6. Bernstein, L.R., and Liotta, L.A. (1994) Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr. Opin. Oncol., 6:106-113.
7. Bianco, P., Fisher, L.W., Young, M.F., Termine, J.D., and Robey, P.G. (1991) Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int., 49:421-426.
8. Bouizar, Z., Spyratos, F., Deytieux, S., Vernejeoul, M.-C., and Jullienne, A. (1993) Polymerase chain reaction analysis of parathyroid hormone related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res., 53:5076-5078.
9. Brown, L.F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E.J., Tognazzi, K., Perruzzi, C.A., Dvorak, H.F., and Senger, D.R. (1994) Osteopontin expression and distribution in human carcinomas. Am. J. Path., 145:610-623.
10. v-subunit. Endocrinology, 132:2432-2440.
11. Chen, Q., Kinch, M.S., Lin, T.H., Burridge, K., and Juliano, R.L. (1994) Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem., 269:26602-26605.
12. Chenu, C., Ibaraki, K., Geron Robey, P., Delmas, P.D., and Young, M.F. (1994) Cloning and sequence analysis of bovine bone sialoprotein cDNA: Conservation of acidic domains, tyrosine sulfation consensus repeats and RGD cell attachment domain. J. Bone Miner. Res., 9:417-421.
13. Clark, E.A., and Brugge, J.S. (1995) Integrins and signal transduction pathways: The road taken. Science, 268:233-238.
14. Clohisy, D.R., Palkert, D., Ramnaraine, M.L.R., Pekurovsky, I., and Oursler, M.J. (1996) Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J. Bone Joint Surg., 14:396-402.
15. Davies, J., Warwick, J., Totty, N., Philip, R., Helrich, M., and Horton, M. (1989) The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J. Cell. Biol., 109:1817-1826.
16. Delannet, M., Martin, F., Bossy, B., Cheresh, D.A., Reichardt, L.F., and Duband, J.-L. (1994) Specific roles of the αvβ1, αvβ3, and αvβ5 integrins in avian neural creast cell adhesion and migration on vitronectin. Development, 120:2687-2703.
17. Duong, L.T., Nutt, E.M., and Rodan, G.A. (1996) Distinct interactions of αvβ3 and αvβ5 vitronectin receptors with extracellular matrix proteins. Abstract, ASBMR 18th annual meeting, M433.
18. Ellon, G., and Mundy, G.R. (1978) Direct resorption of bone by human breast cancer cells in vitro. Nature, 276:726.
19. Fisher, L.W., Whitson, S.W., Avioli, L.V., and Termine, J.D. (1983) Matrix sialoprotein of developing bone. J. Biol. Chem., 258:12723-12727.
20. Fisher, L.W., McBride, O.W., Termine, J.D., and Young, M.F. (1990) Human bone sialoprotein: Deduced protein sequence and chromosomal localization. J. Biol. Chem., 265:2347-2351.
21. Grzesik, W.J., and Robey, P.G. (1994) Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Miner. Res., 9:487-496.
22. Helfrich, M.H., Nesbitt, S.A., Dorey, E.L., and Horton, M.A. (1992) Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. J. Bone Miner. Res., 7:335-343.
23. Hruska, K.A., Rolnick, F., Huskey, M., Alvarez, U., Cheresh, D. (1995) Engagement of the osteoclast integrin αvβ3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology, 136:2984-2992.
24. Hu, D.D., Lin, E.C.K., Kovach, N.L., Hoyer, J.R., and Smith, J.W. (1995) A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5. J. Biol. Chem., 270:26232-2623.
25. Hunter, G.K., and Goldberg, H.A. (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc. Natl. Acad. Sci. USA, 90:8562-8565.
26. Ingram, R.T., Clarke, B.L., Fisher, L.W., and Fitzpatrick, L.A. (1993) Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J. Bone Miner. Res., 8:1019-1029.
27. 1 integrin. Clin. Exp. Metas., 14:19-26.
28. Leavesley, D.I., Ferguson, G.D., Wayner, E.A., and Cheresh, D.A. (1992) Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J. Cell. Biol., 177:1101-1107.
29. Leavesley, D.I., Schwartz, M.A., Rosenfeld, M., Cheresh, D.A. (1993) Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell. Biol., 121:163-170.
30. Liapis, H., Flath, A., and Kitazawa, S. (1996) Integrin αvβ3 expression by bone-residing breast cancer metastasis. Diag. Molec. Path., 5:127-136.
31. Liaw, L., Skinner, M.P., Raines, E.W., Ross, R., Cheresh, D.A., Schwartz, S.M., and Giachelli, C.M. (1995) The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J. Clin. Invest., 95:713-724.
32. Mintz, K.P., Grzesik, W.J., Midura, R.J., Robey, P.J., Termine, J.D., and Fisher, L.W. (1993) Purification and fragmentation of nondenatured bone sialoprotein: Evidence for cryptic, RGD-resistant cell attachment domain. J. Bone Miner. Res., 8:985-995.
33. Mintz, K.P., Midura, R.J., Robey, P.G., and Fisher, L.W. (1994) Purification of bone sialoprotein from the medium of the rat osteoblast-like cell line UMR 106-01BSP. J. Tissue Cult. Methods, 16:2347-2351.
34. Miyamoto, S., Akiyama, S.K., and Yamada, K.M. (1995a) Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science, 267:883-885.
35. Miyamoto, S., Teramoto, H., Coso, O.A., Gutkind, J.S., Burbelo, P.D., Akiyama, S.K., and Yamada, K.M. (1995b) Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol., 131:791-805.
36. Montgomery, A.M., Reisfeld, R.A., and Cheresh, D.A. (1994) Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA, 91:8856-8860.
37. Mundy, G.R. (1991) Mechanisms of osteolytic bone destruction. Bone, 12:S1-S6.
38. Oldberg, A., Franzen, A., and Heinegard, D. (1988a) The primary structure of a cell-binding bone sialoprotein. J. Biol. Chem., 236:19430-19432.
39. Oldberg, A., Franzen, A., Heinegard, D., Pierschbacher, M., and Ruoslahti, E. (1988b) Identification of a bone sialoprotein receptor in osteosarcoma cells. J. Biol. Chem., 263:19433-19436.
40. Orr, W.F., Kostenuik, P., Sanchez-Sweatman, O.H., and Singh, G. (1993) Mechanisms involved in the metastasis of cancer to bone Breast Cane. Res. Treat., 25:151-163.
41. Pasqualini, R., and Hemler, M.E. (1994) Contrasting roles for integrin β1 and β5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. J. Cell. Biol., 125:447-460.
42. Pignatelli, M., Cardillo, M.R., Hanby, A., and Stamp, G.W.H. (1992) Integrins and their accessory adhesion molecules in mammary carcinomas: Loss of polarization in poorly differentiated tumors. Hum. Path., 23:1159-1166.
43. Raynal, C., Delmas, P.D., and Chenu, C. (1996) Bone sialoprotein stimulates in vitro bone resorption. Endocrinology, 137:2347-2354.
44. Ross, F.P., Chappel, J., Alvarez, J.I., Sander, D., Butler, W.T., Farach-Carson, M.C., and Mintz, K.A. (1993) Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J. Biol. Chem., 268:9901-9907.
45. Ruoslahti, E., Noble, N.A., Kagami, S., and Border, W.A. (1994) Integrins. Kidney Int., 45:S17-S22.
46. Shapiro, H.S., Chen, J., Wrana, J.L., Zhang, Q., Blum, M., and Sodek, J. (1993) Characterization of porcine bone sialoprotein: Primary structure and cellular expression. Matrix, 13:431-440.
47. Shankar, G., Gadek, T.R., Burdick, D.J., Davison, I., Mason, W.T., and Horton, M.A. (1995) Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions. Exp. Cell Res., 219:364-371.
48. Sheppard, D. (1996) Epithelial integrins. Bioessays, 18:655-660.
49. Stubbs III, J.T., Eanes, E.D., and Fisher, L.W. (1995) The use of native and recombinant fragments to delineate non-RGD cell attachment domains and mineral-binding domains of bone sialoprotein. J. Bone Miner. Res., 10:8432.
50. Stubbs, J.T. (1997) Generation and use of recombinant human bone sialoprotein and osteopontin for hydroxyapatite studies. Connective Tiss. Res. (in press).
51. Sung, V., Gilles, C., Murray, A., Clarke, R., Aaron, A.D., Azumi, N., and Thompson, E.W. (1998) The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp. Cell Res. (in press).
52. Teti, A., Tiberio, A., Villanova, I., Tacconelli, G., Sciortino, A.F., Chambers, A., Gulino, A., and Mackay, A.R. (1996) The effect of GRGDSP peptide, osteopontin and bone sialoprotein on metalloproteinases tissue inhibitors of metalloproteinases, and plasminogen activators secreted by human osteoclastoma cells. Abstract, ASBMR 18th Annual Meeting: T419.
53. Thompson, E.W., Paik, S., Brunner, N., Sommers, C.L., Zugmaier, G., Clarke, R., Shima, T.B., Torri, J., Donahue, S., Lippman, M.E., Martin, G.E., and Dickson, R.B. (1992) Association of increased basement membrane-invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150:534-544.
54. Thompson, E.W., Brunner, N., Torri, J., Boulay, V., Wright, A., Steeg, P.S., Lippman, M.E., and Clarke, R. (1993) The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin. Exp. Metas., 11:15-26.
55. Thompson, E.W., Sung, V., Lavigne, M., Baumann, K., Azumi, N., Aaron, A.D., and Clarke, R. (1997) LCC15-MB: A vimentin-positive human breast cancer cell line from a femoral bone metastasis. Br. Clin. Exp. Metas. (in press).
56. Tondravi, M., Quiroz, M., Wang, M., and Teitelbaum, S.L. (1996) Increased rate of skeletal metastases by human breast cancer cells expressing low levels of αvβ3 integrin. Abstract, 18th annual ASBMR Meeting, M15.
57. Van der Pluijm, G., Vloedgraven, H.J.M., Ivanov, B., Robey, F., Grzesik, W.J., Robey, P.G., Papapoulos, S.E., and Lowik, C.W.G.M. (1996) Bone sialoprotein peptides are potent inhibitors of breast cancer adhesion to bone. Cancer Res., 56:1948-1955.
58. Van Dijk, S., D'Errico, J.A., Somerman, M.J., Farach-Carson, M.C., and Butler, W.T. (1993) Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J. Bone Miner. Res., 8:1499-1506.
59. Van Muijen, G.N.P., van Kraats, A.A., Ruiter, D.J., and Danen, E.H.J. (1996) Inhibition of invasion and metastasis by transfection of integrin β3 cDNA into a highly metastatic, αvβ3-negative, human melanoma cell line. Abstract, Sixth International Congress of the Metastasis Research Society.
60. Weaver, V.M., Petersen, O.W., Wang, C.A., Larabell, P., Briand, C., Damsky, C., and Bisseil, M.J. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol., 137:231-245.
61. Xuan, J.-W., Hota, C., Shigeyama, Y., D'Errico, J.A., Somerman, M.J., and Chambers, A.F. (1995) Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J. Cell. Biochem., 57:680-690.
62. Yoneda, T., Sasaki, A., and Mundy, G.R. (1994) Osteolytic bone metastasis in breast cancer. Breast Cane. Res. Treat., 32:73-84.
63. Young, M.F., Ibaraki, K., Kerr, J.M., Lyu, M.S., and Kozak, C.A. (1994) Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression and genetic mapping. Mamm. Genome, 5:108-111.
64. Yun, Z., Menter, D.G., and Nicolson, G.L. (1996) Involvement of integrin αvβ3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma. Cancer Res., 56:3103-3111.
65. Zhou, H.-Y., Takita, H., Fujisawa, R., Mizuno, M., and Kuboki, Y. (1995) Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells. Calcif. Tissue Int., 56:403-407.
66. Zutter, M.M., Krigman, H.R., and Santoro, S.A. (1993) Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am. J. Pathol., 142:1439-1448.
67. 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA, 92:7411-7415.